Discontinuation report NOCDURNA
Report ID | 137776 |
Drug Identification Number | 02397927 |
Brand name | NOCDURNA |
Common or Proper name | Desmopressin Orally Disintegrating Tablet |
Company Name | FERRING INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DESMOPRESSIN |
Strength(s) | 25MCG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | SUBLINGUAL SUBLINGUAL |
Packaging size | Blister of 10, 3 blisters per Carton for package of 30 |
ATC code | H01BA |
ATC description | POSTERIOR PITUITARY LOBE HORMONES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-04-30 |
Actual discontinuation date | 2021-04-29 |
Remaining supply date | 2021-04-29 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | 25 mcg stock anticipated to deplete by 30-Apr-2021 |
Company comments | For patients, please discuss alternative treatment options with your health care professional. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2021-04-30 | English | Compare |
v6 | 2021-04-29 | French | Compare |
v5 | 2021-04-29 | English | Compare |
v4 | 2021-04-20 | French | Compare |
v3 | 2021-04-20 | English | Compare |
v2 | 2021-04-20 | French | Compare |
v1 | 2021-04-20 | English | Compare |
Showing 1 to 7 of 7